Lobb; Roy
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lobb; Roy.The latest application filed is for "single domain antibodies against cll-1".
- Lobb; Roy - Wellesley MA
- Lobb; Roy - Westwood MA
| Patent | Date |
|---|---|
| Single Domain Antibodies Against Cll-1 App 20220112292 - Lobb; Roy ; et al. | 2022-04-14 |
| Targeted cancer therapy Grant 11,207,339 - Lobb , et al. December 28, 2 | 2021-12-28 |
| Compositions and methods for tumor transduction Grant 11,059,904 - Lobb , et al. July 13, 2 | 2021-07-13 |
| Compositions And Methods For Treatment Of Cancer App 20210130494 - Lobb; Roy ; et al. | 2021-05-06 |
| Cd19 Variants App 20210079060 - Lobb; Roy ; et al. | 2021-03-18 |
| Compositions And Methods For Tumor Transduction App 20200306375 - Lobb; Roy ; et al. | 2020-10-01 |
| Compositions And Methods For Treatment Of Cancer App 20200255541 - Kind Code | 2020-08-13 |
| Compositions and methods for treatment of cancer Grant 10,669,349 - Lobb , et al. | 2020-06-02 |
| Protein kinase conjugates and inhibitors Grant 10,662,195 - Singh , et al. | 2020-05-26 |
| Compositions and methods for treatment of cancer Grant 10,508,143 - Lobb , et al. Dec | 2019-12-17 |
| Compositions And Methods For Tumor Transduction App 20190112386 - Lobb; Roy ; et al. | 2019-04-18 |
| Targeted Cancer Therapy App 20180311269 - Lobb; Roy ; et al. | 2018-11-01 |
| Targeted Cancer Therapy App 20180311374 - Lobb; Roy ; et al. | 2018-11-01 |
| Compositions and methods for tumor transduction Grant 10,072,094 - Lobb , et al. September 11, 2 | 2018-09-11 |
| Compositions and methods for tumor transduction Grant 10,066,023 - Lobb , et al. September 4, 2 | 2018-09-04 |
| Compositions And Methods For Treatment Of Cancer App 20180142035 - Lobb; Roy ; et al. | 2018-05-24 |
| Compositions And Methods For Tumor Transduction App 20180022821 - Lobb; Roy ; et al. | 2018-01-25 |
| Compositions And Methods For Tumor Transduction App 20170260288 - Lobb; Roy ; et al. | 2017-09-14 |
| Protein Kinase Conjugates and Inhibitors App 20170174691 - Singh; Juswinder ; et al. | 2017-06-22 |
| Protein kinase conjugates and inhibitors Grant 9,556,426 - Singh , et al. January 31, 2 | 2017-01-31 |
| Therapies For Chronic Renal Failure Using One Or More Integrin Antagonists App 20140234299 - Lobb; Roy ; et al. | 2014-08-21 |
| Method for the treatment of inflammatory disorders Grant 8,557,240 - Gotwals , et al. October 15, 2 | 2013-10-15 |
| Method For The Treatment Of Inflammatory Disorders App 20120087925 - Gotwals; Philip ; et al. | 2012-04-12 |
| Method for the treatment of inflammatory disorders Grant 8,084,031 - Gotwals , et al. December 27, 2 | 2011-12-27 |
| Therapies For Chronic Renal Failure Using One Or More Integrin Antagonists App 20110305686 - Lobb; Roy ; et al. | 2011-12-15 |
| Protein Kinase Conjugates and Inhibitors App 20110117073 - Singh; Juswinder ; et al. | 2011-05-19 |
| Method For The Treatment Of Inflammatory Disorders App 20090324598 - Gotwals; Philip ; et al. | 2009-12-31 |
| Method for the treatment of inflammatory disorders Grant 7,462,353 - Gotwals , et al. December 9, 2 | 2008-12-09 |
| Method for the treatment of inflammatory disorders Grant 6,955,810 - Gotwals , et al. October 18, 2 | 2005-10-18 |
| Method for the treatment of inflammatory disorders App 20050226877 - Gotwals, Philip ; et al. | 2005-10-13 |
| Use of a CD40:CD154 binding interruptor to treat immunological complications of the eye App 20030027744 - Dana, M. Reza ; et al. | 2003-02-06 |
| Therapies for chronic renal failure using one or more integrin antagonists App 20030007969 - Lobb, Roy ; et al. | 2003-01-09 |
| Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists App 20020197233 - Relton, Jane ; et al. | 2002-12-26 |
| Method for the treatment of inflammatory disorders App 20020146417 - Gotwals, Philip ; et al. | 2002-10-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 